Mikhail Blagosklonny, a professor, and researcher specializes in cancer and aging. His studies on the prevalence of cancerous cells in aged people yielded a satisfactory result. He discovered the therapy for slowing down aging and rejuvenating immunity against age-related diseases. His discovery of a drug to increase longevity by slowing cancer and aging is a significant success in experimental medicine.Mikhail Blagosklonny also motivated his students and other scientists to engage in studies that will enhance the quality of life. His researches provided a better understanding of complicated medical issues. However, his hypothesis on the use of rapamycin to slow down human aging brought him to the limelight. This cancer treatment has become popular in the medical field.
Education and Career
Mikhail Blagoskoony obtained an M.D and a Ph.D. in internal medicine and experimental medicine and cardiology respectively. He started his career after his study at First Pavlov State Medical University, St. Petersburg. Blagoskoony was later hired at Ordway Research Institute, Albany NY as a senior scientist. His appointment at Roswell Park Cancer Institute as a professor of oncology marked an advancement in cancer therapy.He focused on anti-aging drugs, mechanisms of aging and cancer therapies. These treatments aimed at protecting healthy cells from damage. Through his research in molecular and cellular biology, he was able to develop anti-cancer methods.
Oncotarget cancer research on anti-aging drugs became successful with the discovery of Rapamycin. He proposed the use of this cancer drug in extending life. He established that appropriate dosage of rapamycin could slow aging and consequently cancer. Besides, no side effects have been detected. This achievement was possible through his studies on the combination of anti-cancer drugs and protection of healthy cells.Blagoskloony solved the mystery of the connection between aging and revitalization of the body with rapamycin. The anti-aging properties of this drug made it an ideal agent for cancer therapy. It refreshes the body by reducing destruction of skin cells and cell degeneration. The rejuvenating feature of this medication enables it to slow aging and the growth of cancer cells. Blagoskloony supports the use of this drug to abolish aging and extend human life.With his discovery, he believes that cancer therapy will be a cost-effective treatment in the future. This breakthrough in oncology provides an affordable cancer treatment that is not painful, unlike the current ones. Individuals of different economic status can receive the best cancer therapy.
Blagoskloony has published many articles on his studies. Though he used laboratory animals, he was able to establish the connection between aging and cancerous cells. The anti-cancer drug he discovered not only inhibits the development of tumors, but it also rejuvenates the body.He is the editor-in-chief of the monthly medical journal “Aging.” This publication deals with the aging process. He also held a similar position for Cell Cycle and Cell Death & Differentiation. H these articles have inspired his peers and students to engage in studies that will improve human life.Blagoskloony intends to discover a means of annihilating cancerous cells completely without harming healthy cells after undergoing therapy. However, he hopes other scientists will further his research on cancer treatment.